Ema Partners India Ltd vs Ep Biocomposites Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 19, 2026

Key Highlights

The Latest Trading Price of EMA Partners India Ltd is ₹ 79.1 as of 18 Mar 15:30 . The P/E Ratio of EMA Partners India Ltd changed from 20.3 on March 2025 to 20.3 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of EP Biocomposites Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of EMA Partners India Ltd changed from ₹ 256.64 crore on March 2025 to ₹ 256.64 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of EP Biocomposites Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The Dividend Payout of EMA Partners India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of EP Biocomposites Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About EMA Partners India Ltd

EMA Partners India Limited was originally incorporated as a Private Limited Company in the name and style of 'Executive Management Associates India Private Limited' dated September 9, 2003.
The Company name was changed from 'Executive Management Associates India Private Limited' to 'EMA Partners India Private Limited' pursuant to fresh Certificate of Incorporation dated February 4, 2004 issued by the RoC, Mumbai, Maharashtra.
Subsequently, the status was converted into Public Limited Company and the name of the Company was changed to 'EMA Partners India Limited' and a fresh Certificate of Incorporation was issued by RoC, Central Processing Centre on August 05, 2024. The Company is a leading executive search firm delivering bespoke leadership hiring solutions to clients across diverse sectors.

About EP Biocomposites Ltd

EP Biocomposites Limited was incorporated as Public Limited Company on January 17, 2020 with the Registrar of Companies, Goa.
Further, pursuant to Business Takeover Agreement dated August 31, 2021, the Company took over the running business of M/s.
OM Ventures, a proprietorship concern through one of its Promoter Leena Kamat.
In September 2022, Company made an Initial Public Offer of 5,04,000 Equity Shares of Rs 10 each by raising funds aggregating to Rs. 6.35 Crore. The Company is involved in manufacturing and supplying of a vast portfolio of products and services, which includes Fibre Glass doors and allied products, Bio Digester Toilets with DRDO technology and actively contributing to wastewater recycling through its solution in Sewage Treatment Plants (STP)and Effluent Treatment Plants (ETP).

FAQs for the comparison of EMA Partners India Ltd and EP Biocomposites Ltd

Which company has a larger market capitalization, EMA Partners India Ltd or EP Biocomposites Ltd?

Market cap of EMA Partners India Ltd is 183 Cr while Market cap of EP Biocomposites Ltd is 16 Cr

What are the key factors driving the stock performance of EMA Partners India Ltd and EP Biocomposites Ltd?

The stock performance of EMA Partners India Ltd and EP Biocomposites Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for EMA Partners India Ltd and EP Biocomposites Ltd?

As of March 19, 2026, the EMA Partners India Ltd stock price is INR ₹79.1. On the other hand, EP Biocomposites Ltd stock price is INR ₹99.0.

How do dividend payouts of EMA Partners India Ltd and EP Biocomposites Ltd compare?

To compare the dividend payouts of EMA Partners India Ltd and EP Biocomposites Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.